Page 2,368«..1020..2,3672,3682,3692,370..2,3802,390..»

Mesenchymal Stem Cells Market- MSC Product is Stem Cells Fastest Growing Area Says New Research Report at …

Posted: May 13, 2013 at 12:45 pm

Dallas, Texas (PRWEB) May 12, 2013

Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of growth accelerated in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

Revealing Unique Strategic Opportunities & Unknown Competitive Advantages MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in Mesenchymal stem cells research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. The report advantageously positions companies that wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

Expanded and Updated Market Intelligence This is an expanded and updated market intelligence report that includes:

Highlights of this report http://www.reportsnreports.com/reports/10598-mesenchymal-stem-cells-advances-applications.html include:

These sources were used to identify recent advances in MSC research applications, explore research priorities by market segment, highlight individual labs and end-users of MSC research products, explore the competitive environment for MSC research products, and provide 5-year growth and trend analysis. As such, this market intelligence report will advantageously position ones company to offer competitive MSC products to this rapidly growing, well-funded research community.

Can also access information on:

In summary, literature and data concerning the biology and differentiation potential of mesenchymal stem cells (MSCs) has become huge in less than 10 years, now totaling nearly 13,000 publications, although some data does present as contradictory, suggesting a heterogenic nature for MSC populations depending on source tissue, species, and donor characteristics. MSCs appear to be an exceptionally promising tool for cell therapy because of their unusual characteristics, which partially mimic those of embryonic stem cells, but have advantages in terms of availability, expandability, transplantability, and ethical implications.

Here is the original post:
Mesenchymal Stem Cells Market- MSC Product is Stem Cells Fastest Growing Area Says New Research Report at ...

Posted in Stem Cells | Comments Off on Mesenchymal Stem Cells Market- MSC Product is Stem Cells Fastest Growing Area Says New Research Report at …

Hot off the Grill: Burgers Made From Billions of Stem Cells

Posted: May 13, 2013 at 12:45 pm

May 13, 2013 12:15pm

(Image Credit:Francois Lenoir/Reuters)

A Dutch scientist hopes hell change minds about the viability of test tube meat when his first genetically engineered hamburger, made from billions of stem cells, is served hot off the grill.

Mark Post, the head of physiology at Maastricht University in the Netherlands, has spent years growing the synthetic hamburger from bovine stem cells, which his teamturned into thin strips of muscle tissue before mincing them into a patty.

RELATED: Lab-Grown Meat: Food of the Future?

While the process has taken time and run upconsiderable expense the project received $325,000 from an anonymous donor Post told the New York Times he hoped the cost of cultured meat could come down in the future, making it a viable food source.

After conducting an informal tasting, Post gave the synthetic tissue his seal of approval, telling the Times, it tastes reasonably good and that he planned to add just salt and pepper before serving it, perhaps at an event in London this summer.

Post told ABC News in 2011 that he expected meat consumption to double in the next 40 years.

In my mind, meat consumption is here to stay, and if you want to do that at a higher efficiency than what is currently done by cows and pigs, you have to explore the possibility of doing that in the lab, he said.

Read more:
Hot off the Grill: Burgers Made From Billions of Stem Cells

Posted in Stem Cells | Comments Off on Hot off the Grill: Burgers Made From Billions of Stem Cells

Study uses stem cells, fat to repair skin

Posted: May 13, 2013 at 12:45 pm

A new study that's based in Baltimore is exploring the use of stem cells and fat grafting for cosmetic and reconstructive procedures.

As people age, the fat in their face decreases, and that can often make people look older.

A woman in her 60s who 11 News did not identify said she wanted to freshen her look but didn't want to go through a face-lift operation like she did several years before. Instead, Mercy Medical Center's Dr. Craig Vander Kolk used her own fat stem cells.

"By using fat, we can reshape all of that and build it up," Vander Kolk said, pointing to areas upon which the woman wanted to improve.

He is currently conducting a fat-grafting study at Mercy in which he takes the fat stem cells from a patient's abdomen. They are then used cosmetically and for breast reconstruction, among other things.

"If we use them in areas where there's been an injury, they help heal the injury. If we take fat and stem cells, we can make the skin more healthy, improve scars and improve diseases that can cause the skin to thin," Vander Kolk said.

He said fat is better for cosmetic procedures because, while fillers need to be repeated every six months or year, the stem cells and fat stay, leaving a longer-lasting result.

Continue reading here:
Study uses stem cells, fat to repair skin

Posted in Stem Cells | Comments Off on Study uses stem cells, fat to repair skin

Stem Cell Therapy at Pondicherry East Coast Hospitals – Video

Posted: May 13, 2013 at 12:42 pm


Stem Cell Therapy at Pondicherry East Coast Hospitals

By: Anupama Karthikeyane

Read the original here:
Stem Cell Therapy at Pondicherry East Coast Hospitals - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Stem Cell Therapy at Pondicherry East Coast Hospitals – Video

Kilian Before

Posted: May 13, 2013 at 12:42 pm


Kilian Before After Stemlogix Stem Cell Therapy

By: Jim Cain

See the original post:
Kilian Before

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Kilian Before

WARF hESC Patent Update: Seven Years and Challenge Still Underway

Posted: May 12, 2013 at 8:13 pm

Last week UC Davis stem cell researcher
Paul Knoepfler and Scripps researcher Jeanne Loring engaged in an
online Q&A that touched on patents and how they can stifle
research and discourage development of therapies.

Loring did not mention it in the Q&A
but she is the key figure in the ongoing challenge to the WARF
(Wisconsin Alumni Research Foundation)
patents on human embryonic
stem cells. Her effort began in 2006 but has dropped out of the news.
We asked her for an update on the case.
Here is the text of what she replied,

Dan Ravicher is the lawyer behind
several big patent cases, including the recent Supreme Court case
challenging human gene patenting (Myriad), and a challenge to
Monsanto's restrictive enforcement of its patents on genetically
modified seeds. 

“I'm lucky that he is also the lawyer
working with John M. Simpson (of Consumer Watchdog) and me to
challenge the WARF patents.  Currently, we are getting ready for
another year of appeals and counter-appeals on the third of WARF's
three patents that give them control over all human embryonic stem
cells.

“This is Dan's summary of the current
situation:

"'We filed challenges at the
Patent Office to all three of WARF's hESC patents. During those
challenges, WARF agreed to narrow all three of the patents, and
they also loosened their licensing requirements. But, even
though the patents were narrowed, we still think they're invalid, and
thus disagree with the Patent Office's decision to re-issue them in
the narrowed forms. Unfortunately, due to the age of the patents and
changes in the law, we were only allowed to appeal one of the three
decisions, and that appeal is now pending at the Court of Appeals in
Washington. But, we expect the decision in our appeal will affect
the validity of the other two patents, since they're all basically
on the same technology." 

“The 'narrowing' of the patents has
had an unexpected consequence.  Before the narrowing, WARF's
patents would have covered iPSCs as well as hESCs. After the
narrowing, they can only claim hESCs.”

In the Q&A on Knoepfler's blog,
which also involved an interesting discussion of IPS research,
Loring said,

Patents
on fundamental things
--
genes, human embryonic stem cells, iPS cells
--
allow the patent holder to have a monopoly, preventing anyone else
from using whatever they’ve patented.

Patents
are supposed to stimulate investment in development.  Why, as
Justice Scalia said last week, would anyone have the incentive to
study a gene and, for example, develop diagnostic tests, if they
couldn’t prevent everyone else from working on that gene?

But
patents also stifle competition and the advances that come from
having many different groups studying the genes or cells.  One
of the main reasons I returned to academia was so I could have
freedom to study human ES cells without worrying about getting
threatening letters from a patent holder, demanding that I either
stop working on the cells or pay a steep licensing fee.

There
will inevitably be problems commercializing iPSC-based therapies and
assays, because at least three institutions own patents on aspects of
iPSCs.  I’m paying attention to the patent
'landscape,'
but have decided to deal with those problems when they arise, and
hope that the iPSC patent holders realize that the potential of these
cells is too great to keep to themselves.  It would be better
for all of us if the issue of stem cell patents never has to be
decided in the Supreme Court.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/fXlAaqQbBAs/warf-hesc-patent-update-seven-years-and.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on WARF hESC Patent Update: Seven Years and Challenge Still Underway

University of Toronto: Stem Cells, From Hype to Hope – Video

Posted: May 12, 2013 at 1:44 pm


University of Toronto: Stem Cells, From Hype to Hope
Teaching old cells young tricks: stem cell researchers can turn back the clock on mature cells, reverting them to immature cells that can generate any tissue...

By: universitytoronto

Originally posted here:
University of Toronto: Stem Cells, From Hype to Hope - Video

Posted in Stem Cell Videos | Comments Off on University of Toronto: Stem Cells, From Hype to Hope – Video

Blood vessels and stem cells for arthritis treatment – Video

Posted: May 12, 2013 at 1:44 pm


Blood vessels and stem cells for arthritis treatment
http://www.stemcellsarthritistreatment.com Researchers at the Cornell University School of Medicine have discovered that endothelial cells, cells that line b...

By: Nathan Wei

See the article here:
Blood vessels and stem cells for arthritis treatment - Video

Posted in Stem Cell Videos | Comments Off on Blood vessels and stem cells for arthritis treatment – Video

Webinar: Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Clinical Trial – Video

Posted: May 12, 2013 at 1:44 pm


Webinar: Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Clinical Trial
Title: Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Trial in 12 Patients Speaker: Jonathan D. Glass, M.D. Pro...

By: CIRMTV

Excerpt from:
Webinar: Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Clinical Trial - Video

Posted in Stem Cell Videos | Comments Off on Webinar: Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Clinical Trial – Video

Semilleros de investigación Stem Cells – Universidad El Bosque – Video

Posted: May 12, 2013 at 1:44 pm


Semilleros de investigacin Stem Cells - Universidad El Bosque
Club de revista Semilleros de investigacin grupo Stem Universidad El Bosque.

By: camixis

Read more here:
Semilleros de investigación Stem Cells - Universidad El Bosque - Video

Posted in Stem Cell Videos | Comments Off on Semilleros de investigación Stem Cells – Universidad El Bosque – Video

Page 2,368«..1020..2,3672,3682,3692,370..2,3802,390..»